摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}piperazin-2-one | 620629-15-4

中文名称
——
中文别名
——
英文名称
1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}piperazin-2-one
英文别名
1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)-adenine-9-yl]-acetyl}-piperazin-2-one;benzhydryl N-[9-[2-[4-(1,3-benzothiazol-2-ylsulfonyl)-3-oxopiperazin-1-yl]-2-oxoethyl]purin-6-yl]carbamate
1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}piperazin-2-one化学式
CAS
620629-15-4
化学式
C32H26N8O6S2
mdl
——
分子量
682.74
InChiKey
RIDFVDDMFUZNJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    48
  • 可旋转键数:
    9
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    206
  • 氢给体数:
    1
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}piperazin-2-one 、 T-monomer 、 、 aminomethyl-terminated Tentagel resin 、 5-[4-(9-fluorenylmethoxycarbonyl)amino-3,5-dimethoxyphenoxy]pentanoic acid 生成
    参考文献:
    名称:
    PNA monomer and precursor
    摘要:
    该应用程序涉及通式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法: 其中 E为氮或C—R′;J为硫或氧; R′、R1、R2、R3、R4独立地为H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基、苯基或卤代苯基, R5为H或天然或非天然α-氨基酸的保护或未保护侧链;以及 B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
    公开号:
    US20030225252A1
  • 作为产物:
    描述:
    N-[2-(benzothiazole-2-sulfonylamino)ethyl]-N-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}glycine盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 6.0h, 以92%的产率得到1-(benzothiazole-2-sulfonyl)-4-{[6-N-(benzhydryloxycarbonyl)adenin-9-yl]acetyl}piperazin-2-one
    参考文献:
    名称:
    Peptide Nucleic Acid Synthesis by Novel Amide Formation
    摘要:
    Synthesis of self-activated peptide nucleic acid (PNA) monomers and an efficient method for PNA synthesis using a benzothiazole-2-sulfonyl (Bts) group as an amine-protecting group as well as an acid-activating group are reported. Couplings were complete within 120 min, and the deprotection was performed in 10 min. This Bts strategy provides a high purity PNA oligomer and is appropriate for large-scale synthesis. The results of the 15-mer PNA oligomer are described.
    DOI:
    10.1021/ol071215h
点击查看最新优质反应信息

文献信息

  • [EN] PNA MONOMER AND PRECURSOR<br/>[FR] MONOMERE ET PRECURSEUR PNA
    申请人:PANAGENE INC
    公开号:WO2003091231A1
    公开(公告)日:2003-11-06
    This application relates to monomers of the general formula (I) for the preparation PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: (I) wherein E is nitrogen or C-R'; J is sulfur or oxygen; R', Rl, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, RS is H or protected or unprotected side chain of natural or unnatural a-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    该应用程序涉及通用式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法:(I)其中E为氮或C-R'; J为硫或氧; R',Rl,R2,R3,R4独立地为H,卤素,烷基,硝基,腈基,烷氧基,卤代烷基,卤代烷氧基,苯基或卤代苯基,RS为H或天然或非天然α-氨基酸的保护或未保护侧链; B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
  • PNA monomer and precursor
    申请人:——
    公开号:US20030225252A1
    公开(公告)日:2003-12-04
    This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: 1 wherein E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural &agr;-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    该应用程序涉及通式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法: 其中 E为氮或C—R′;J为硫或氧; R′、R1、R2、R3、R4独立地为H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基、苯基或卤代苯基, R5为H或天然或非天然α-氨基酸的保护或未保护侧链;以及 B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
  • Method of making PNA oligomers
    申请人:Kim Kee Sung
    公开号:US20060003374A1
    公开(公告)日:2006-01-05
    This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: wherein E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    该应用程序涉及一般式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供预定义序列PNA寡聚体和随机序列PNA寡聚体的合成方法:其中E是氮或C-R′; J是硫或氧; R′、R1、R2、R3、R4独立地是H、卤素、烷基、硝基、腈、烷氧基、卤代烷基、卤代烷氧基、苯基或卤代苯基,R5是H或保护或未保护的天然或非天然α-氨基酸侧链; B是天然或非天然的核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对弱到中等碱稳定但对酸敏感的保护基保护。
  • US6969766B2
    申请人:——
    公开号:US6969766B2
    公开(公告)日:2005-11-29
  • US7125994B2
    申请人:——
    公开号:US7125994B2
    公开(公告)日:2006-10-24
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐